Erasca (ERAS) IPO Opens Fractionally Lower

Go back to Erasca (ERAS) IPO Opens Fractionally Lower

Erasca, Inc (ERAS) Announces Upsized 18.75M Share Offering at $16/sh

July 16, 2021 4:58 AM UTC

Erasca, Inc. (NASDAQ: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of its upsized initial public offering of 18,750,000 shares of common stock at an initial public offering price of $16.00 per share. All of the shares are being offered by Erasca. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Erasca, are expected to be $300.0 million. In addition, Erasca has granted the... More